Olema Pharmaceuticals, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Olema Pharmaceuticals announces its 2026 Annual Meeting of Stockholders, scheduled for June 17, 2026, to elect directors, approve executive compensation, and ratify auditor selection.
NASDAQ
Olema Pharmaceuticals will hold its annual stockholder meeting virtually on June 10, 2025, to vote on director elections, executive compensation, and auditor ratification.
NASDAQ
Olema Pharmaceuticals announces its 2025 Annual Meeting of Stockholders to be held virtually on June 10, 2025, featuring proposals for director elections, executive compensation, and auditor ratification.
NASDAQ
Olema Pharmaceuticals announces its annual stockholder meeting to be held virtually on June 13, 2024, with proposals including the election of directors, executive compensation approval, and ratification of the company's independent auditor.
NASDAQ
DEF 14A: Olema Pharmaceuticals Sets Date for 2024 Annual Stockholders Meeting, Outlines Key Proposals
Olema Pharmaceuticals will hold its 2024 Annual Meeting of Stockholders virtually on June 13, 2024, to vote on director elections, executive compensation, and auditor ratification.